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FOLLOWING on from previous findings that 3: 4-benzpyrene is metabolised
to two distinct derivatives, BPX and BPF, which differ in chemical properties
andfluorescence spectra (Chalmers and Peacock, 1936; Chalmers, 1938; Chalmers
and Crowfoot, 1941), Weigert and Mottram (1946) succeeded in isolating four
different metabolites symbolised as X1, X2, F1 and F2. The X derivatives only
were extractable from the liver, bile and small intestine whereas the F derivatives
were present as major metabolites in the large intestine and faeces. The F
derivatives were also found when tissues containing the X metabolites were
stored for any length of time. In view ofthe apparent metabolic transformation
and chemical properties of the derivatives and by analogy with the known
metabolic fate of the non-carcinogenic hydrocarbon, anthracene, they postulated
the following oxidative mechanism.
The groups R1 and R2 were not identified but an acidic nature was postulated
for them.
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The metabolite F2 proved to be identical with 8-hydroxy-3: 4-benzpyrene
previously identified as an end product in the faeces (Berenblum, Crowfoot,
Holiday and Schoental, 1943).
This reasoning, however, has been criticised by Berenblum and Schoental
(1955) who argue that the long wave systems of the absorption spectra of X1
and X. are very similar to those of fully aromatic benzpyrene derivatives and
that F1 is indistinguishable from unconjugated 10-hydroxy-3: 4-benzpyrene
previously identified in faeces (Berenblum and Schoental, 1946).K. H. HARPER
In view of the finding that the metabolism of the non-carcinogenic hydro-
carbon pyrene proceeds via tissue intermediates possessing the fully aromatic
pyrenoid configuration (Harper, 1958) it seemed desirable therefore to re-examine
the metabolism of 3: 4-benzpyrene iin the hope of resolving this controversy.
MATERIALS AND METHODS
Mice of RIII, Strong A, C.B.A. and Swiss strains were used for these experi-
ments. Each mouse received an intravenous injection of 0 5 c.c. of a colloidal
dispersion of 3: 4-benzpyrene containing 1 mg. per c.c. The animals were then
killed at intervals of 1 to 4 hours depending upon the particular organ under
investigation.
The duodenum and small intestine and the caecum and large intestine were
subjected to an extraction procedure essentially that devised by Weigert and
Mottram (1946) except that silica gel (100/200 mesh) was used in preference to
silica (100/150 mesh) for chromatography. This modification was found to
give a much higher development rate and cleaner products on elution with
ethyl alcohol.
RESULTS
(a) Gall bladder
For examination of bile the animals were killed after 1 hour. The bright
blue fluorescent bile was first extracted with ether but this removed only a small
amount of fluorescent material. After acidification, however, an ether extract
possessed a strong blue/white fluorescence and when examined spectroscopically
was found to possess a fully aromatic benzpyrenoid type spectrum. It was
obtained free from colouring matter by the method previously described for the
3-hydroxypyrene glucuronide (Harper, 1957), that is by evaporating a solution
in slightly moist ether and washing the residue with several small volumes of
benzene. The residue dissolved in ethyl alcohol possessed absorption maxima
at 257, 267, 287, 298, 361, 379 and 412 m/t and in view of the absorption spectra
obtained subsequently for purified X1 and X2 it was considered to contain a
mixture of these two derivatives.
A solution ofthe mixture in water possessed an intense blue/white fluorescence
which remained unchanged on the addition of alkali.
A sample, heated in dilute hydrochloric acid at 1000 C. for 10 minutes, assumed
a yellow colour and on extraction with benzene followed by chromatography on
alumina yielded a bright yellow/green fluorescent zone near the surface and a
reddish coloured, orange fluorescent zone moving slowly down the column.
On elution with ethyl alcohol the yellow/green fluorescent zone yielded a blue
fluorescent solution which spectroscopically appeared to be the F1 of Weigert
and Mottram. However, attenuation of the 395 and 418 m,u absorption bands
suggested the presence of an additional substance. The orange fluorescent zone
was similar in appearance and behaviour to synthetic benzpyrene-5: 8-quinone
but the small quantity available prevented complete characterisation.
A further sample of the mixture was incubated at 370 C. with ,8-glucuronidase
(bacterial) at pH 7 for 2 hours. An ether extract of the incubated mixture was
then colourless with a strong blue/white fluorescence. When examined spectro-
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scopically it was found to possess the characteristic spectrum of F1 but once
again with attenuated 395 and 418 mut absorption bands.
(b) Duodenum and small intestine
For examination of this tissue the animals were killed at 1 I to 2 hours. The
final appearance of the chromatogram was essentially as described by Weigert
and Mottram, namely a diffuse bright blue fluorescent zone extending downwards
from the surface of the silica.
In one experiment the whole of this zone was eluted with ethyl alcohol,
transferred to water and incubated at 37° C. with fl-glucuronidase at pH 7 for
2 hours. An ether extract of the mixture then possessed the characteristic
F1 spectrum but with the same attenuated 395 and 418 m/t absorption bands
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FIG. 1.-Absorption spectra in ethyl alcohol. 1. X1 transcribed from Weigert and Mottram
(1946). 2. X1 as isolated in present work.
referred to above. On transferring to hexane these bands appeared as doublets
with maxima respectively at 392 and 395-396 m,t and 415 and 419 m,u.
In a further experiment separation of the blue fluorescent zone on the silica
gel into X1 and X2 was carried out by development with amyl alcohol as described
by Weigert and Mottram.
X, metabolite.-The initial filtrate from the column was yellow in colour and
non-fluorescent and accordingly was discarded. The remainder of the filtrate
was diluted with 10 times its volume of petroleum ether (b.p. 40-60° C.) and the
mixture rechromatographed on silica gel. The X1 was obtained as a colourless,
bright blue/white fluorescent zone beneath the surface. When eluted with ethyl
alcohol and examined spectroscopically the X1 was found to possess a fully aro-
matic benzpyrenoid type spectrum (Fig. 1) with maxima at 256, 266, 286, 298,
363, 369, 379, 388 and 408-409 m,t with an inflection at 352-354 m,.
The purified X1 was transferred to water and the following reactions observed.
(1) On heating in dilute hydrochloric acid at 100° C. for 10 minutes the X1
was converted into pure F1 and what appeared to be benzpyrene-5: 8-quinone.
(2) On incubation at 370 C. with f8-glucuronidase at pH7 for 2 hours it was
converted almost quantitatively into pure F1 (spectrum Fig. 2). Accordingly,
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in view of its physical, chemical and biochemical behaviour allied with the new
spectroscopic evidence which rules out the postulated diol type structure, it is
concluded that the X1 metabolite is the glucuronide conjugate of F1.
X2 metabolite.-After removal of X1 from the silica gel chromatogram by
prolonged development with amyl alcohol the whole of the column possessed a
blue/white fluorescence with a greater intensity at the surface. The surface
zone, when eluted with ethyl alcohol, yielded a yellow coloured solution possessing
the spectrum shown in Fig. 2. Attempts to separate the X2 from the apparent
strongly absorbing background were unsuccessful but the indications are that
X2, like X1, also possesses the fully aromatic benzpyrenoid configuration.
FIG. 2.-Absorption spectra in ethyl alcohol. 1. X2 transcribed from Weigert and Mottram
(1946). 2. X2 as isolated in present work.
The crude X2 thus obtained was incubated at 370 C. with /5-glucuronidase at
pH 7. After 2 hours a sample of the incubated mixture gave a fluorescence
colour change from blue to green on addition of alkali. On extraction and
chromatography on silica gel over alumina a small amount of unchanged X2
was identified on the silica gel and a bright yellow/green fluorescent zone which
appeared to be predominantly F1 was obtained on the alumina.
It would appear therefore that X2 is converted into F1 and not F2 by the
enzymatic activity of fi-glucuronidase. Unfortunately the possibility of con-
tamination with X1 cannot be ruled out, since, as was stated above, the whole
of the silica gel possessed a blue/white fluorescence. Accordingly no definite
conclusion can be drawn at present but it is perhaps significant that what was
considered to be a purer sample of X2 isolated from bile also yielded F1 on enzy-
matic hydrolysis with ,8-glucuronidase.
(c) Caecum and large intestine
For examination of these organs the animals were killed after 4 hours. The
extract was then found to contain F1 as the major metabolite with only a trace
amount of X derivatives. Once again however, the 395 and 418 m,u maxima of
the F1 were considerably attenuated and in hexane appeared as doublets with
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maxima at 302 and 396 m,t and 415 and 419 m/,t. The presence of 8-hydroxy-
3: 4-benzpyrene and possible trace of 5- or 10-hydroxy derivatives in the
mixture was subsequently established by methylation and fluid chromatography.
The nature of the F1 metabolite.-In distinction to the sky blue fluorescent
appearance of F1 adsorbed on alumina reported by Weigert and Mottram,
throughout these experiments F1 has appeared on the alumina chromatogram
from benzene as a bright yellow/green fluorescent zone moving slowly down the
column on development with solvent.
On addition of sodium hydroxide to a solution ofF1 in alcohol the fluorescence
colour change from blue to yellow has occurred immediately and this behaviour
was considered to be more in keeping with a free phenolic nature rather than the
conjugated structure postulated by Weigert and Mottram.
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FIG. 3.-Absorption spectra in hexane. 1. F1. 2. Methylated Fl.
Accordingly, in view ofthe conclusion arrived at by Berenblum and Schoental
that F1 is indistinguishable from unconjugated 10-hydroxy-3: 4-benzpyrene,
methylation of the pure F1 obtained by hydrolysis of the purified X1 with
,/-glucuronidase was carried out.
Methylation was effected with dimethyl sulphate and excesssodiumhydroxide,
the reaction being continued until the mixture no longer exhibited a yellow
fluorescence in ultraviolet light. The mixture was then extracted with benzene
and the benzene extract chromatographed on alumina. The methylated F1
passed rapidly down the column and was collected in the filtrate. Further
purification was effected by transference to cyclohexane followed by chromato-
graphy on alumina. The methylated derivative was obtained as a homogeneous
blue/white fluorescent zone moving slowly down the column on prolonged develop-
ment with solvent. It was eluted with ethyl alcohol and transferred to hexane
for spectroscopic examination. The absorption spectrum (Fig. 3) is very similar
to that of the F1 with maxima at 259-260, 268, 287, 301, 342, 359, 378, 390 and
413 m/t. On comparison with the absorption spectra of the methylated metabo-
lites of 3: 4-benzpyrene previously identified in faeces, namely 8-benzpyrenol
(Berenblum et al., 1943), 10-benzpyrenol (Berenblum and Schoental, 1946)
and 5-benzpyrenol (Pihar and Spcleny, 1956) it is seen that the absorption spec-
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trum of methylated F1 does not correspond to any of these (Table I). However,
in view of the fact that F1 readily undergoes oxidation to what appears to be
the 5: 8-quinone it seems likely that the hydroxyl group is at either the 5 or 8
position of the molecule. If this is so then the difference in spectral properties
must be attributed to the presence of an additional group in the molecule.
TABLE I
(Transcribed in part from Pihar and Spa'leny, 1956)
3: 4-Benzpyrene
derivative Maxima in hexane-m,u
(metabolic) Source A-
F, . . . 261 268 - 287 301 342 358-359 378 392 415
Methylated F, . . 259-260 268 - 287 301 342 359 378 390 413
8-Methoxy- a . - - 293 307 - 362 379 397 420
10-Methoxy- . b . 257 267 278 287 297-5 347 374 5 395 411-5
5-methoxy- . . c 256 266 274 287 299 - 357 375 395 409
a and b.-Berenblurn and Schoental, 1946.
c.-Pihar and Spaleny, 1956.
The F derivatives from the caecum and large intestine.-As was stated earlier
spectroscopic examination of the F derivatives taken from the caecum and large
intestine suggested that F1 was the predominant component but that a small
amount of an additional derivative was also present. Accordingly the mixture
was methylated and chromatographed on alumina from cyclohexane as described
above. The column was then developed with cyclohexane containing an
increasing amount ofbenzene and the filtrate collected in fractions. The fractions
were then transferred to alcohol and examined spectroscopically.
The spectrum of the first fraction was indeterminate but the presence of a
distinct maximum at 408 m,t suggested the presence of a trace amount of either
the 10-methoxy or the 5-methoxy derivative. Successive fractions were then
identified as containing 8-methoxy-benzpyrene, mixtures of the 8-methoxy
and methylated F1 derivative and finally methylated F1 alone.
It is concluded therefore that the attenuation of the 395 and 418 m,t absorp-
tion bands ofF1 in alcohol referred to previously is due largely to the presence of
a small amount of 8-hydroxy-3: 4-benzpyrene.
Attempted conversion of F1 to F2
As evidence for their postulated conjugated structure for F1 Weigert and
Mottram stated that F1 was converted into 8-hydroxy-3: 4-benzpyrene by pro-
longed heating in sulphuric acid.
Attempts to repeat this transformation have proved unsuccessful. Thus
on heating with 0 5 N sulphuric acid in the presence of air the F1 was rapidly
converted to a non-fluorescent compound which appeared on an alumina chromato-
gram as a red zone with an orange fluorescence similar to that of synthetic 5: 8-
quinone. Owing to the small amount of derivative involved however, attempts
to effect further characterisation by reductive methylation were not successful.
When the heating was carried out under nitrogen for as long a period as 8 hours
the F1 was recovered unchanged.
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Attempts to convert F1 into F2 by enzymatic activity proved equally
insuccessful. Thus F1 was recovered unchanged after incubation with fi-
glucuronidase or with an homogenate of caecum and large intestine taken from
untreated mice.
DISCUSSION
Contrary to the assertion of Weigert and Mottram that in mixtures ofF1 and
F2 in alcohol the last two bands in the absorption spectrum appear as doublets
this phenomenon has not been observed during the present experiments. It is
concluded from the methylation experiments carried out on the F derivatives
isolated from the caecum and large intestine that the effect of a small amount of
8-hydroxy-3: 4-benzpyrene on a solution of F1 in alcohol is merely to attenuate
the 395 and 418 m,u absorption bands ofthe F1.
Accordingly it is suggested by these experiments that, during the first hour
following intravenous injection of benzpyrene, F1 and F2 are eliminated in the
bile as glucuronide conjugates, that of F1 being considerably in excess of the F2
conjugate. This mixture then passes unchanged through the duodenum and
small intestine and is hydrolysed to the phenols F1 and F2 during subsequent
passage through the caecum andlargeintestine. Thefindings ofMarsh, Alexander
and Levvy (1952) with respect to the intestinal distribution of glucuronide
decomposing enzymes, referred to in the preceding communication on the inter-
mediary metabolism of pyrene, once again provide important circumstantial
evidence in support ofthis view.
From the physical, chemical and biochemical properties of X1 cited above the
glucuronide conjugate of F1 is considered to be Xl. It is tempting to conclude
therefore that X2 is a similar conjugate of F2 but the experimental evidence does
not support this view. No positive conclusion can be drawn at present however,
owing to the impurity of the X2 obtained and the possible contamination with
X1 metabolite.
It appears therefore that this metabolic sequence presents an analogous
case to that found for the non-carcinogenic pyrene. The major, and perhaps
important, difference, lies in the presence of two distinct metabolic pathways
in the case of 3: 4-benzpyrene. Further experiments are to be carried out with
other hydrocarbons to determine whether there is an association between an
alternative metabolic mechanism and the carcinogenic process.
SUMMARY
(1) The intermediary metabolite X1 of 3: 4-benzpyrene has been found to
possess the fully aromatic benzpyrenoid configuration and its physical, chemical
and biochemical properties are consistent with it being the glucuronide conjugate
ofF1.
(2) The experimental evidence suggests that F2 is also present in the bile
and small intestine as a glucuronide conjugate, but the evidence is not consistent
with this conjugate being the X2 metabolite. However, owing to the impure
nature of the X2 obtained no definite conclusion can be drawn at present.
(3) The full absorption spectrum ofthe end product F1 has been recorded and
is consistent with a fully aromatic benzpyrenoid configuration for this compound.
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(4) F1 on methylation has yielded a derivative which differs spectroscopically
from the methylated derivatives of the 8-, 10- and 5-benzpyrenols previously
identified in faeces.
(5) The metabolism of 3: 4-benzpyrene is discussed in relation to that of the
non-carcinogenic pyrene.
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ADDENDUM
Since this paper was submitted for publication the author's attention has
been drawn to the suggestion by Chalmers (1956) that 3: 4-benzpyrene is meta-
bolised in the liver to hydroxy derivatives which are conjugated with glucuronic
acid. The metabolites are then excreted either in the urine or in the faeces
after hydrolysis in the gut.
In a more recent communication Conney, Miller and Miller (1957) have reported
that 3: 4-benzpyrene is metabolised by fortified rat liver homogenate to a mixture
of the 8- and 10-benzpyrenols and an unidentified compound corresponding to
the F1 of Weigert and Mottram together with small amounts of 5: 8- and 5: 10-
quinones and 5: 8-dihydroxy-3: 4-benzpyrene. The properties of the F1
resembled those of a monohydroxy-benzpyrene and on methylation yielded a
derivative with absorption maxima at 412, 389, 377, 358, 299, 285, 258, and 240
m,u. In the longer wave band region these are in close agreement with-he
absorption maxima obtained for methylated F1 duFing the present experiment~.
They also report, however, that their F1 band, upon methylation, yielded
appreciable amounts of 8-methoxy-benzpyrene in addition to the methylated F1.
In the present experiments a similar mixture was obtained upon methylation of
the F1 zone isolated from the large intestine and caecum, but a pure sample
of F1, obtained by /8-glucuronidase hydrolysis of the X1 metabolite, yielded only
methylated F1.
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